OCULAR THERAPEUTIX INC (OCUL)

US67576A1007 - Common Stock

5.97  -0.32 (-5.09%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
59.84M58.44M51.49M43.52M17.40M
Cost Of Goods
5.39M5.28M4.54M4.41M2.08M
Gross Profit
54.44M53.16M46.95M39.12M15.32M
Operating Expenses
145.91M135.54M125.61M117.15M78.17M
Research and Development
67.04M61.05M53.46M50.08M28.69M
Selling, General, and Administrative Expenses
78.86M74.49M72.15M67.07M49.47M
Operating Income
-91.45M-82.38M-78.65M-78.04M-62.85M
Interest Income/Expense
-10.05M-12.54M7.62M71.48M-92.79M
Other Income/Expense
N/A-1.00K0.000.00N/A
Non Recurring Items
N/A14.19MN/AN/AN/A
Income Before Taxes
-115.27M-80.74M-71.04M-6.55M-155.64M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-115.27M-80.74M-71.04M-6.55M-155.64M
EBITDA
-88.02M-79.40M-76.54M-75.62M-60.08M
 
Per Share Data
EPS Diluted Total Ops
-1.09-1.01-0.92-0.09-2.56
Non GAAP EPS
-1.48-1.17-0.96-0.09-2.47
 
Statistics
Gross Profit Margin
90.97%90.96%91.18%89.89%88.05%
Profit Margin
-192.61%-138.14%-137.97%-15.05%-894.48%
Operating Profit Margin
-152.81%-140.96%-152.75%-179.32%-361.21%

All data in USD

Charts